CELCUITY INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
CELCUITY INC. (CELC) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 15.69 thousand shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-23.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2022-03-23
- CELCUITY INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2020-03-31 was 0.00 shares.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2019-12-31 was 0.00 shares.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2019-09-30 was 0.00 shares.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2019-06-30 was 2.57K shares, a 51.03% decline year-over-year.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2021 was 15.69K shares.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2020 was 0.00 shares, a 100.00% decline from fiscal 2019.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2019 was 2.57K shares, a 51.03% decline from fiscal 2018.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2018 was 5.25K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | 15.69K shares 10-K · filed 2022-03-23 | ||||
| 2020-12-31 | 0.00 shares 10-K · filed 2022-03-23 | ||||
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-07 | 0.00 shares derived: sum of 2 quarters · filed 2021-02-16 | 0.00 shares derived: sum of 3 quarters · filed 2021-02-16 | 2.57K shares derived: sum of 4 quarters · filed 2021-02-16 | |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | 0.00 shares derived: sum of 2 quarters · filed 2021-02-16 | 2.57K shares derived: sum of 3 quarters · filed 2021-02-16 | 2.57K shares 10-K · filed 2021-02-16 | |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 2.57K shares derived: sum of 2 quarters · filed 2019-11-07 | 2.57K shares 10-Q · filed 2019-11-07 | 2.57K shares derived: sum of 4 quarters · filed 2020-05-07 | |
| 2019-06-30 | 2.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 2.57K shares 10-Q · filed 2019-08-08 | 2.57K shares derived: sum of 3 quarters · filed 2020-05-07 | 2.57K shares derived: sum of 4 quarters · filed 2020-05-07 | |
| 2019-03-31 | 0.00 shares 10-Q · filed 2020-05-07 | 0.00 shares derived: sum of 2 quarters · filed 2020-05-07 | 0.00 shares derived: sum of 3 quarters · filed 2020-05-07 | 5.25K shares derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | 0.00 shares derived: sum of 2 quarters · filed 2020-03-13 | 5.25K shares derived: sum of 3 quarters · filed 2020-03-13 | 5.25K shares 10-K · filed 2020-03-13 | 0.00 shares 10-K · filed 2019-03-01 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 5.25K shares derived: sum of 2 quarters · filed 2019-11-07 | 5.25K shares 10-Q · filed 2019-11-07 | 5.25K shares derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | 5.25K shares 10-Q · filed 2018-08-09 | 5.25K shares 10-Q · filed 2019-08-08 | 5.25K shares derived: sum of 3 quarters · filed 2019-03-01 | 5.25K shares derived: sum of 4 quarters · filed 2019-03-01 | |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2019-03-01 | 0.00 shares derived: sum of 3 quarters · filed 2019-03-01 | 0.00 shares derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | 0.00 shares derived: sum of 2 quarters · filed 2019-03-01 | 0.00 shares derived: sum of 3 quarters · filed 2019-03-01 | 0.00 shares 10-K · filed 2019-03-01 | |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2018-11-13 | 0.00 shares 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | 0.00 shares 10-Q · filed 2018-08-09 | 0.00 shares 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | 0.00 shares 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |